The number of people with susceptibility test result for rifampicin in Fiji
Fiji: The number of people with susceptibility test result for rifampicin was 96.21 in 2021. ▼ Falling
Latest (2021)
96.21
Change on year
down 3.8%
World rank
45th
of 146 countries
All-time high
109.63
in 2018
All-time low
96.21
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Fiji, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Fiji recorded 96.21 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.
Compared with earlier readings it is down 3.8% on the previous year and down 3.8% over five years.
Fiji ranks 45th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Fiji, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 100 | — |
| 2018 | 109.63 | +9.6% |
| 2019 | 100 | -8.8% |
| 2020 | 100 | +0.0% |
| 2021 | 96.21 | -3.8% |
Fiji compared with similar countries
- Fiji's 96.21 is above the median for upper middle income countries, which is 92.7, 1.0× the median. (45 countries reporting)
- Fiji's 96.21 is below the median for East Asia & Pacific, which is 96.47, 100% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 103.21 | 100 | 109.63 | 3 |
| 2020s | 98.11 | 96.21 | 100 | 2 |
Countries ranked near Fiji
More health data for Fiji
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4425 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,339 deaths per 1,000 people (2090)
- Number of infants who die before age 1 77 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2023)
- Population ages 00-04, female, annual growth rate -0.9576 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.042 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8116 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Fiji?
- The number of people with susceptibility test result for rifampicin in Fiji was 96.21 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Fiji?
- The highest recorded value was 109.63 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Fiji?
- The lowest recorded value was 96.21 in 2021.
- How does Fiji rank for the number of people with susceptibility test result for rifampicin?
- Fiji ranks 45th out of 146 countries with data for 2021.
- Where does this Fiji data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).